Human Cathepsin D
Native whole molecule & biologically active
Produktdetails
Synonyms
CatD, CTSD, CPSD
Description of Human Cathepsin D
Human Cathepsin D is a 42 kDa protein. Cathepsin D (CatD), a lysosomal aspartyl protease encoded by the CTSD gene, functions in protein degradation and activation of bioactive precursors through cleavage at acidic pH. Its structure includes a signal peptide, propeptide, and catalytic domain with two aspartic residues essential for enzymatic activity. Estrogen receptor (ER) signaling drives CatD overexpression in hormone-responsive breast cancers via TATA-dependent transcription initiation, mediated by upstream stimulatory factors USF-1/USF-2 binding to E-box elements. In ER-positive tumors, CatD secretion promotes metastasis by degrading extracellular matrix components and enhancing cell motility. Clinically, CatD expression correlates with aggressive breast cancer phenotypes, including high histological grade, and reduced survival. In Alzheimer’s disease (AD), CatD colocalizes with amyloid-β (Aβ) plaques and neurofibrillary tangles, where it degrades both Aβ42 and tau under normal conditions. However, Aβ42 accumulation competitively inhibits CatD, impairing tau clearance and exacerbating neurodegeneration. Cigarette smoke elevates CatD activity in alveolar macrophages and bronchoalveolar lavage fluid, contributing to emphysema via lung matrix degradation. Therapeutically, CatD serves as a prognostic biomarker for breast cancer stratification and a predictor of tamoxifen resistance. Inhibitors like pepstatin A and small-molecule analogs targeting its active site are under investigation for metastatic breast cancer and AD3. In smokers, monitoring BALF CatD levels (>3, 600 U/mL) may identify early lung damage, guiding preventive interventions. These dual roles in proteostasis and disease underscore CatD’s potential as a multifunctional therapeutic node.
Source
Prepared from liver shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA-required tests.
Biological Activity
≥ 300 units per mg protein. One unit is defined as the amount of enzyme that digests hemoglobin-releasing peptides, which are soluble in 10% TCA. The reaction is measured by an increase in A280 of 1.0 per 60 minutes at 37 °C.
Storage
For long term, store Human Cathepsin D at ≤ -20°C.
Applications
Cancer, Alzheimer's, In Vitro Diagnostic.
Citations/Publications
Kryštůfek, R., et al., (2021), 'Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery', J. Med. Chem., 64: pp 6706−6719. Available at: https://doi.org/10.1021/acs.jmedchem.0c02177
Lambeth, T. R., et al., (2021), 'Proteolysis of Amyloid β by Lysosomal Enzymes as a Function of Fibril Morphology', ACS Omega, 6: pp 31520−31527. Available at:https://doi.org/10.1021/acsomega.1c03915
NCBI: https://www.ncbi.nlm.nih.gov/protein/P07339
Shipped with ice packs
Gel Scan of Human Cathepsin D
Fig. 1: SDS-PAGE Gel |
Usage: For research use only. Not for use in diagnostic or therapeutic procedures. Not for human use.
To buy Human Cathepsin D please click on the Shopping List Symbol right from the indicated price. This will add Human Cathepsin D to your Shopping List. You can then click on the button »Shopping List & Order Form« to ask for a quote. We will send you your quote as soon as possible. Our offer will include institutional discounts where applicable.
For business customers only. All prices are net prices (excluding VAT). Final prices in our quote will contain VAT plus shipping costs if applicable. For further information please go to our Shipping page.
Errors, changes and availability excepted.


Payment Methods
Paying by bank transfer
